NPS MedicineWise selling access to its GP patient data program
Updated: 30 August 2016
NPS MedicineWise is accepting drug company money for providing analyses of patient data provided by hundreds of GP practices.
The not-for-profit is currently tasked with promoting quality prescribing.
But there is a heated debate about its activities after it emerged last week it had set up a commercial subsidiary called VentureWise, which has organised a GP education program with $214,000 from drug company giant GSK.
Australian Doctor has now been told VentureWise is also selling access to the NPS